These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 11057405

  • 1. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K, Franke WG, Kropp J, Koch R, Runge R, Hliscs R.
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [Abstract] [Full Text] [Related]

  • 2. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H, Bender H, Schomburg A, Grünwald F, Schöneich G, Zamorra P, Reichmann K, Dierke-Dzierzon C, Mallmann P, Biersack HJ.
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [Abstract] [Full Text] [Related]

  • 3. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R, Festa A, Pasqualoni R, Semprebene A, Rea S, Bergomi S, Maini CL.
    Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
    [Abstract] [Full Text] [Related]

  • 4. Systemic radionuclide therapy in pain palliation.
    Liepe K, Runge R, Kotzerke J.
    Am J Hosp Palliat Care; 2005 Mar; 22(6):457-64. PubMed ID: 16323716
    [Abstract] [Full Text] [Related]

  • 5. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R, Séra T, Pajor L, Thurzó L, Láng J, Csernay L, Pávics L.
    Orv Hetil; 2000 May 07; 141(19):1019-23. PubMed ID: 10846424
    [Abstract] [Full Text] [Related]

  • 6. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K, Hliscs R, Kropp J, Grüning T, Runge R, Koch R, Knapp FF, Franke WG.
    Cancer Biother Radiopharm; 2000 Jun 07; 15(3):261-5. PubMed ID: 10941533
    [Abstract] [Full Text] [Related]

  • 7. [Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
    Hauswirth AE, Palmedo H, Dierke-Dzierzon C, Biersack HJ, Krebs D.
    Zentralbl Gynakol; 1998 Jun 07; 120(2):83-6. PubMed ID: 9531713
    [Abstract] [Full Text] [Related]

  • 8. Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases.
    Limouris GS, Shukla SK, Condi-Paphiti A, Gennatas C, Kouvaris I, Vitoratos N, Manetou A, Dardoufas C, Rigas V, Vlahos L.
    Anticancer Res; 1997 Jun 07; 17(3B):1767-72. PubMed ID: 9179232
    [Abstract] [Full Text] [Related]

  • 9. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO, Ibiş E, Aras G, Baltaci S, Ozalp G, Bedük Y, Canakci N, Soylu A.
    Ann Nucl Med; 2000 Aug 07; 14(4):239-45. PubMed ID: 11023023
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
    Liepe K, Kropp J, Runge R, Kotzerke J.
    Br J Cancer; 2003 Aug 18; 89(4):625-9. PubMed ID: 12915868
    [Abstract] [Full Text] [Related]

  • 11. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G, Palmedo H, Dierke-Dzierzon C, Müller SC, Biersack HJ.
    Scand J Urol Nephrol; 1997 Oct 18; 31(5):445-8. PubMed ID: 9406304
    [Abstract] [Full Text] [Related]

  • 12. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K, Kropp J, Hliscs R, Franke WG.
    Clin Nucl Med; 2000 Nov 18; 25(11):901-4. PubMed ID: 11079588
    [Abstract] [Full Text] [Related]

  • 13. Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
    Zafeirakis A, Zissimopoulos A, Baziotis N, Limouris GS.
    Q J Nucl Med Mol Imaging; 2011 Feb 18; 55(1):91-102. PubMed ID: 21068716
    [Abstract] [Full Text] [Related]

  • 14. Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer.
    Limouris G, Shukla SK, Manetou A, Kouvaris I, Plataniotis G, Triantafyllou N, Rigas AV, Vlahos L.
    Anticancer Res; 1997 Feb 18; 17(3B):1699-704. PubMed ID: 9179222
    [Abstract] [Full Text] [Related]

  • 15. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
    Klutmann S, Bohuslavizki KH.
    MMW Fortschr Med; 1999 Nov 04; 141(44):38-9. PubMed ID: 10912142
    [Abstract] [Full Text] [Related]

  • 16. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG, Preston DF, Schiefelbein M, Baxter KG.
    JAMA; 1995 Aug 02; 274(5):420-4. PubMed ID: 7542352
    [Abstract] [Full Text] [Related]

  • 17. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
    Lange R, Overbeek F, de Klerk JM, Pasker-de Jong PC, van den Berk AM, Ter Heine R, Rodenburg CJ, Kooistra A, Hendrikse NH, Bloemendal HJ.
    Nuklearmedizin; 2016 Sep 26; 55(5):188-95. PubMed ID: 27443809
    [Abstract] [Full Text] [Related]

  • 18. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.
    Liepe K, Runge R, Kotzerke J.
    J Cancer Res Clin Oncol; 2005 Jan 26; 131(1):60-6. PubMed ID: 15449184
    [Abstract] [Full Text] [Related]

  • 19. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ.
    J Nucl Med; 1991 Oct 26; 32(10):1877-81. PubMed ID: 1717669
    [Abstract] [Full Text] [Related]

  • 20. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
    Dafermou A, Colamussi P, Giganti M, Cittanti C, Bestagno M, Piffanelli A.
    Eur J Nucl Med; 2001 Jul 26; 28(7):788-98. PubMed ID: 11504074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.